KIWI Biolab, a high-tech laboratory specializing in automated methods and model-based bioprocess engineering, will make its expertise available to the new research center “The Simulated Human.”

The Fish Growth Physiology Working Group at Research Institute for Farm Animal Biology (FBN) in Dummerstorf, together with the Academy for Animal Welfare of the German Animal Welfare Federation, is hosting a three-day fish cell culture course in October.

A team led by Prof. Sina Bartfeld from the Technical University of Berlin, Department of Medical Biotechnology, has developed an intestinal organoid model that can be used to investigate the infection route of the bacterial intestinal pathogen EPEC (enteropathogenic Escherichia coli). As a result, the scientists were able to identify an effective, natural defense mechanism of the intestinal mucosal cells. 

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has published a draft opinion on the reliability and reproducibility of a new animal-free methodology in preclinical research. This methodology replaces animal control groups conducted in parallel with animal testing by virtual control groups. This is intended to reduce the total number of laboratory animals—usually rats—used in dose-finding studies. 

Each year, four outstanding doctoral students from around the world are selected for the Science & SciLifeLab Prize. In addition to prize money of up to $30,000, the winners will be invited to SciLifeLab in Stockholm in December, where they can present their research findings, network with leading scientists, and celebrate science through a series of unique events.

The Federal Ministry of Agriculture, Food, and Home Affairs (BMLEH) has announced the 2026 Animal Welfare Research Award in two categories. The nomination deadline has been extended to April 12, 2026.  

At the Einstein Center for Early Disease Interception (EC-EDI), researchers from leading Berlin-based research institutions aim to explore new avenues for prevention and bring them to application more quickly. Over the next six years, the scientists will drive the development, integration, and application of key technologies to achieve this goal.

The College of Veterinary Medicine and Biomedical Sciences at Texas A&M University, located 150 kilometers north of Houston, Texas, will be home to a new research center: the NAMs Decision Center. It is being funded by the National Institutes of Health (NIH) with $15.3 million. The five-year grant will advance modern, science-based approaches (NAMs) to improve and accelerate chemical safety assessments while reducing the need for new animal testing.

On March 18, the National Institutes of Health (NIH) announced more than $150 million in funding for the development and scaling of research methods that better simulate human biology and reduce reliance on animal models—a priority of the Trump administration.

Researchers at Johns Hopkins University will receive $15 million to develop a platform to study neurological diseases and test chemicals using “novel methodological approaches” that do not involve animal testing.

Page 1 of 105